64
Research Trials
29
Peer-reviewed publications
17
Clinical Conditions

Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.
18 November 2025 · ERS Congress 2025

This investigator-led feasibility trial from the NeuroCOUGH Clinical Research Collaboration tested whether a definitive study of azithromycin's effect on cough and oesophageal motility in chronic respiratory disease is achievable, pairing continuous cough monitoring with repeated high-resolution oesophageal manometry (HROM). Thirty patients with chronic cough and established respiratory disease were monitored continuously for one week before and four weeks during open-label azithromycin 250 mg daily using the Hyfe Cough Tracker, with HROM performed at baseline and at four weeks. Recruitment hit three patients per month at a single centre, 87% completed all visits, and every pre-specified data quality outcome met its stop-go criterion. Notably, 52% of patients had abnormal oesophageal function at baseline, and among those who underwent repeat HROM, 42% showed greater than 30% improvement in distal contractile integral after treatment. The findings establish feasibility for a definitive trial examining the gut-lung axis in respiratory disease and identify DCI as a viable outcome measure.
Bring objective cough data to your study. Schedule a meeting →